Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Journal of Neuro-Oncology|March 16, 2017
Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for GlioblastomaManohan Sinnadurai, Kerrie L McDonaldBrain Pathology (Zurich, Switzerland)|August 22, 2019
Intracranial ependymomas: molecular insights and translation to treatmentAshleigh Lester, Kerrie L McDonaldJournal of Neuro-Oncology|February 23, 2016
The challenges associated with molecular targeted therapies for glioblastomaToni Rose Jue, Kerrie L McDonaldNanomedicine (London, England)|September 2, 2020
Lanthanum nanoparticles to target the brain: proof of biodistribution and biocompatibility with adjuvant therapiesVictor M Lu, Kerrie L McDonaldJournal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 13, 2017
The current evidence of statin use affecting glioblastoma prognosisVictor M Lu, Kerrie L McDonaldCNS Oncology|January 6, 2018
Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in gliomaVictor M Lu, Kerrie L McDonaldFrontiers in Neurology|January 25, 2013
Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?Kerrie L McDonald, Grace Aw, Paul KleihuesGenomics|February 6, 2022
DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosisHumaira Noor, Shane Whittaker, Kerrie L McDonaldFrontiers in Oncology|December 10, 2015
CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?Lisette B W Schröder, Kerrie L McDonaldScientific Reports|October 24, 2020
Cytotoxic lanthanum oxide nanoparticles sensitize glioblastoma cells to radiation therapy and temozolomide: an in vitro rationale for translational studiesVictor M Lu, Toni Rose Jue, Kerrie L McDonaldPageof 7